Prospective, historically controlled study to evaluate the efficacy and safety of a new paediatric formulation of nifurtimox in children aged 0 to 17 years with Chagas disease one year after treatment (CHICO)

Nifurtimox is a recommended treatment for Chagas disease, but data from treated children are limited. We investigated the efficacy, safety and tolerability of nifurtimox administered as divisible, dispersible 30 mg and 120 mg tablets in children with Chagas disease. In this blinded, controlled study...

Descripción completa

Detalles Bibliográficos
Autores principales: Altcheh, Jaime, Castro, Luis, Dib, Juan C., Grossmann, Ulrike, Huang, Erya, Moscatelli, Guillermo, Pinto Rocha, Jimy José, Ramírez, Teresa Estela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790535/
https://www.ncbi.nlm.nih.gov/pubmed/33412557
http://dx.doi.org/10.1371/journal.pntd.0008912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790535/
https://www.ncbi.nlm.nih.gov/pubmed/33412557
http://dx.doi.org/10.1371/journal.pntd.0008912

Ejemplares similares